HALO Market Cap & Key Metrics
Halozyme Therapeutics, Inc.
$110.42
+$0.58(+0.53%)
66
Overall
60
Value
75
Tech
65
Quality
Market Cap
$12.47B
Volume
1.85M
52W Range
$61.23 - $116.85
Target Price
$99.00
HALO market cap is $12.47B. This page lists Halozyme Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
HALO Key Metrics
- Market cap
- $12.47B
- P/E ratio (current-year EPS estimate)
- 13.38
- EPS estimate, current year
- $8.25
- EPS growth, 3-year
- +21.28%
- Value score
- 60
- Quality score
- 65
- Technical score
- 75
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.40B | $1.02B | $829.25M | $660.12M | $443.31M |
| EBITDA | $580.56M | $663.89M | $459.27M | $323.35M | $259.04M |
| EPS | $2.64 | $3.50 | $2.13 | $1.48 | $2.86 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HALO | $110.42 | +0.5% | 1.85M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Halozyme Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW